← Eichor
Study identifier: NCT06576583 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.

Condition: Patellofemoral Osteoarthritis  ·  Sponsor: University Hospital, Basel, Switzerland

PhasePhase 2
Planned participants150
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

ENCANTO is a randomized, controlled, multi-center phase II clinical trial for the treatment of patellofemoral osteoarthritis (PFOA) with an Advanced Therapy Medicinal Product (ATMP), nasal chondrocyte-based tissue engineered cartilage (N-TEC) implantation in comparison with current standard of care depending on the stage of osteoarthritis. The goal of this phase II trial is to evaluate the efficacy of N-TEC treatment in comparison to an active comparator Autologous Matrix Induced Chondrogenesis (AMIC) for early stage PFOA or patellofemoral arthroplasty (PFA) for late stage PFOA. The N-TEC engineered cartilage graft is obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane.

This description comes directly from the study's public registry record.

Talk to the study team

Marcus Mumme, MD  ·  +41 44 387 29 77  ·  marcus.mumme@usb.ch

Gyözö Lehoczky, MD  ·  +41 61 704 2615  ·  Gyözö.Lehoczky@ukbb.ch

Always discuss trial participation with your own doctor first.

Locations (11)

Orthopedic Hospital Vienna-SpeisingVienna, AustriaRecruiting
University Hospital Sveti DuhZagreb, CroatiaNot Yet Recruiting
Evangelisches Waldkrankenhaus SpandauBerlin, GermanyNot Yet Recruiting
Orthopedic Clinic König-Ludwig-HausWürzburg, GermanyRecruiting
IRCCS Ospedale Galeazzi-Sant'AmbrogioMilan, ItalyRecruiting
Fondazione Policlinico Universitario Campus Bio-MedicoRome, ItalyNot Yet Recruiting
Maastricht University Medical CenterMaastricht, NetherlandsNot Yet Recruiting
Zeromski hospitalKrakow, PolandRecruiting
Department of Orthopaedics, University of Gothenburg (UGOT)Mölndal, SwedenRecruiting
University Hospital BaselBasel, SwitzerlandRecruiting
CrossklinikBasel, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06576583